IDEXX Laboratories, Inc. (IDXX) Tops Q1 EPS by 2c; Increases FY11 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $551.21 -4.3%
Revenue Growth %: +8.2%
Financial Fact:
General and administrative: 52.63M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: +8.2%
Financial Fact:
General and administrative: 52.63M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $292.7 million versus the consensus estimate of $285.61 million.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- IDEXX Laboratories (IDXX) PT Lowered to $627 at UBS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
